Correlation Between Assertio Therapeutics and Alkermes Plc
Can any of the company-specific risk be diversified away by investing in both Assertio Therapeutics and Alkermes Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assertio Therapeutics and Alkermes Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assertio Therapeutics and Alkermes Plc, you can compare the effects of market volatilities on Assertio Therapeutics and Alkermes Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assertio Therapeutics with a short position of Alkermes Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assertio Therapeutics and Alkermes Plc.
Diversification Opportunities for Assertio Therapeutics and Alkermes Plc
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Assertio and Alkermes is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Assertio Therapeutics and Alkermes Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alkermes Plc and Assertio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assertio Therapeutics are associated (or correlated) with Alkermes Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alkermes Plc has no effect on the direction of Assertio Therapeutics i.e., Assertio Therapeutics and Alkermes Plc go up and down completely randomly.
Pair Corralation between Assertio Therapeutics and Alkermes Plc
Given the investment horizon of 90 days Assertio Therapeutics is expected to under-perform the Alkermes Plc. In addition to that, Assertio Therapeutics is 2.51 times more volatile than Alkermes Plc. It trades about -0.03 of its total potential returns per unit of risk. Alkermes Plc is currently generating about 0.2 per unit of volatility. If you would invest 2,653 in Alkermes Plc on August 28, 2024 and sell it today you would earn a total of 283.00 from holding Alkermes Plc or generate 10.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Assertio Therapeutics vs. Alkermes Plc
Performance |
| Timeline |
| Assertio Therapeutics |
| Alkermes Plc |
Assertio Therapeutics and Alkermes Plc Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Assertio Therapeutics and Alkermes Plc
The main advantage of trading using opposite Assertio Therapeutics and Alkermes Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assertio Therapeutics position performs unexpectedly, Alkermes Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alkermes Plc will offset losses from the drop in Alkermes Plc's long position.| Assertio Therapeutics vs. Amneal Pharmaceuticals, Class | Assertio Therapeutics vs. Lifecore Biomedical | Assertio Therapeutics vs. Ironwood Pharmaceuticals | Assertio Therapeutics vs. Neurocrine Biosciences |
| Alkermes Plc vs. Intracellular Th | Alkermes Plc vs. Ironwood Pharmaceuticals | Alkermes Plc vs. Pacira BioSciences, | Alkermes Plc vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |